We have established the clonal relationships between the hematopoietic precursors residing in the bone marrow (BM) and the peripheral blood (PB) of mice treated with granulocyte colony-stimulating factor (G-CSF). The use of animals whose hematopoiesis was reconstituted with genetically labeled stem cells has allowed us to show that an almost identical repertoire of clones is found in the colony-forming unit (CFU-S) population present in the BM and mobilized PB. Moreover, our data has shown that the frequency of expression of the repopulating clones in both types of CFU-S populations is the same, evidencing that G-CSF mobilized PB progenitor cells (PBPCs) closely reflect the clonal makeup ofthe hematopoietic precursors residing in the BM. When secondary recipients were transplanted with BM or mobilized P6 grafts that had been harvested from the genetically OBILIZED PERIPHERAL. blood progenitor cells (PBPCs) are being increasingly used as a source of hematopoietic support in the transplantation of patients bearing solid tumors and hematologic malignan~ies,"~ and represent a suitable target population for gene-therapy and genemarking
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The main advantages of using PBPCs in place of bone marrow (BM) in clinical transplantation protocols include the more rapid hematopoietic recovery of transplanted recipiout general anaesthesia, and the feasibility of harvesting the graft from patients with BM fibrosis. One additional advantage, yet to be formally shown,14 is derived from the potential reduced risk of tumor-cell contamination ascribed to PBPCs.
Previous studies have shown that the administration of hematopoietic growth factors (HGFs), either alone or in combination with cytotoxic drugs, efficiently mobilizes the hematopoietic progenitors from the BM, hence reducing the number of harvests required for the collection of PBPC Although several HGFs are capable of inducing mobilization of hematopoietic progenitors, granulocyte colony-stimulating factor (G-CSF) is at present one of the most efficient mobilizing molecules used both in experimental models and clinical protocols. The efficiency of G-CSF to mobilize BM precursors and long-term repopulating cells (LTRCs) was initially shown in early preclinical studies. In this respect, Moulinex et all* observed a marked increase of the colony-forming unit (CFU-S) pool, one of the most primitive clonogenic precursors in the mouse hematopoietic system, in the PB of mice treated with repeated doses of G-CSF. In addition, it was observed that G-CSF alone," and more significantly in combination with stem cell factor (SCF)" or interleukin-7 (IL-7);' mobilizes hematopoietic precursors capable of both confemng radioprotection and generating a sustained lympho-hematopoiesis in transplanted recipients. More recently, the multipotential repopulating capacity of G-CSFISCF mobilized PBPCs has been reported in the mouse model through the genetic labeling of these cells with retrovird vectors. ' The accumulated in vitro data from human patients is consistent with the notion that the quality of human mobi-M ents,L.10-13 the abili.ty to collect the hematopoietic graft withBlood, Vol 88, No 7 (October l ) , 1996 pp 2495-2501 marked mice, the presence of long-term lympho-hematopoietic repopulating clones was showed not only in the BM but also in the PB samples. No new clones were identified in the long-term repopulating cells of the mobilized animals with respect to those found in the CFU-S population. Moreover, the hematopoietic precursors that were capable of long-term reconstitution corresponded to the clones, which were most highly represented in the CFU-S compartment, suggesting, at least in the case of G-CSF treated mice, that the frequency of expression of the repopulating clones in the CFU-S population is prognostic for the clone longevity. Based on our experimental data, new advantages for the use of mobilized PBPCs in place of hematopoietic grafts procured from limited areas of BM are proposed. lized PBPCs is at least equivalent to that corresponding to BM grafts,22-24 and thus with the hypothesis indicating that mobilized PBPCs contain the true lympho-hematopoietic stem cells. Consequently, recent trials of allogenic PBPC transplantation have been initiated with the belief that no failures in the hematopoiesis will be produced in the longterm."
Despite all this biological and clinical data, no information concerning the clonal relationships between BM and mobilized PBPCs has yet been reported. Therefore, questions as to whether mobilized PBPCs arise from particular subpopulations of BM precursors or from a generalized mobilization of the precursors residing in the BM are still open to discussion. By the introduction of genetic markers into the longterm repopulating hematopoietic stem cells2' we have defined the clonal repertoire of hematopoietic precursors present in the BM and the PB of G-CSF treated mice and, thus, have defined the clonal relationships between both types of hematopoietic grafts. This approach has, in addition, allowed us to evaluate the repopulating and multipotential capacity of mobilized PBPCs with respect to the precursor clones that reside in the BM. For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From Mobilization was performed 4 months (mice 4.1 and 4.2) or 11 months (mouse 11.1) after the transplantation of 10' genetically-marked BM cells. Clones with a predominant (+++), moderate (++) and weak (+) repopulating capacity are represented in the hematopoietic organs (see also in Figs 2 and 3) . Data in the CFU-S boxes represents the ratio of positivehotal spleen colonies analyzed. (LTR) Clones with long-term repopulating potential (see Fig 5) .
' Clones not studied in long-term retransplantation experiments.
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From VARAS. BERNAD, AND BUEREN mice were killed by cervical dislocation to dissect the hematopoietic organs. BM cells were flushed from both femora and tibiae with Iscove's modified Dulbecco's medium (IMDM; GIBCO Laboratories, Grand Island, NY), dispersed by repeated passes through a 21-gauge needle and counted in hematocytometer. Aliquots of heparinized PB and BM cell suspensions were then transplanted into irradiated recipients for CFU-S and LTRC assays.
The exogenous spleen colony forming unit (CFU-S) precursor was assayed according to the method described by Till and McCulloch.26 PB and BM grafts were injected via the lateral tail vein of recipients that had been previously irradiated with a split dose of 10 Gy (two doses of 5 Gy spaced 4 hours apart). Twelve days after transplantation, recipients were killed and their spleens removed and fixed in Telleyesniczky's solution to determine the number of spleen colonies under a dissecting microscope. When molecular analysis was required, individual colonies were dissected and processed for DNA extraction immediately after the mice were killed. For analyzing the presence of LTRCs in the hematopoietic grafts, recipients were conditioned with a 24-hour split dose of 12 Gy (two doses of 6 Gy spaced 24 hours apart). This protocol represents an optimized radiation conditioning, capable of allowing both a predominant engraftment of the transduced graft and a high survival rate of the transplanted recipients." In the longterm after transplantation (4 to 11 months posttransplantation), recipient mice were killed and their lympho-hematopoietic organs excised and analysed by Southern blotting (discussed later). Irradiation was delivered in all instances at a dose rate of 1.03 Gy/min, using a Philips MG324 x-ray equipment (Philips, Hamburg, Germany) at 300 kV, 12.8 mA (HVL:3.2 mm Cu).
Infective supematants bearing the pXTl retroviral vector were used. This vector transcribes the phosphotransferase neomicine (neo') gene from the Moloney Murine Leukaemia Virus LTR.28 To produce retroviral supematants a pXT1-infected Jlz clone rendering titers of 1 to 3 X IO6 cfu neo'/mLZ5 was grown in 1% of gelatin-pretreated plates (BioRad Labs, Richmond, CA) and fed with IMDM supplemented with 5% fetal bovine serum (FBS; GIBCO Laboratories). When confluency was reached, cells were recharged with fresh medium, and 24-hours later the retroviral supernatants were procured, clarified by centrifugation, filtered through 0.8 pm and stored at -80°C. According to the marker rescue assay, no helper virus was detected in supernatants nor in the serum of animals, which had been transplanted with transduced grafts.
BM grafts were transduced according to the VE/S protocol described previously." BM cells were procured 4 to 5 days after a single intravenous injection of 150 mg/kg body weight of 5-fluorouracil (5-FU; Roche, Basel, Switzerland) to 12-week-old male mice. Dispersed BM cells were diluted to 1 to 2 X los cells/mL with infective supematants supplemented with 20% FBS, 20% WEHI-3b conditioned medium (WCM) as a source of mIL-3, 0.2 U/mL rmSCF (kindly provided by Genetics Institute, Cambridge, MA), and 5 pg/mL of polybrene (Aldrich Chemical Co, Milwaukee, WI). The multiplicity of infection, defined as the number of infectious particles (cfu neor assay) per BM cell, was kept close to or above 5. After a 6 hour infection period, cells were washed and further incubated at a final concentration of 1 to 2 X lo6 cells/ mL in fresh IMDM supplemented with 20% FBS, 20% WCM, and 4 U/mL of SCF. Two days after the infection, 1 mg/mL of G418 (equivalent weight of active product) was added to the culture media and maintained for a 24-hour period. Finally, cells were collected, washed, and transplanted into irradiated female mice.
Lympho-hematopoietic tissues were homogenized with 500 pg/mL proteinase Kin 10 mmoll L Tris pH 7.5, 0.5% sodium dodecyle sulfate (SDS), IO mmoVL EDTA pH 8.0, and 150 mmol/L NaCI. After overnight (oh) digestion at 5YC, DNA was phenol-extracted and ethanol-precipitated,
CFU-S and LTRC assays.

Retroviral vectors and virus-producing cell lines.
Gene transfer protocol.
Southern analyses of reconstituted mice. essentially as previously de~cribed.'~ Genomic DNA samples (10 pg) were digested with BamHI (Boehringer Mannheim, Mannheim, Germany), an enzyme that does not cleave to the provirus, electrophoresed on 0.8% agarose gels and transferred onto Gene Screen Plus nylon membranes (Dupont NEN Research Products, Boston, MA) using the alkaline method for DNA." Integrated pXTl retroviral sequences were developed by hybridization of blots with a 1,200-bp fragment of the neor gene, and labeled with cu-"P-dCTP by random priming." Membranes were prehybridized for 3 hours at 42°C in 10 mmoVL Tris pH 7.5, 50% formamide, 5 X sodium chloridelsodium citrate buffer (SSC), 5 x Denhardt's reagent, 0.5% SDS, and then hybridized o/n under the same conditions but supplemented with 10% dextran-sulphate and 50 pg/mL denatured camer DNA. Membranes were washed three times, 1 hour each, at 56°C in 0.1 X SSC, 0.5% SDS, once in 2 x SSC and exposed wet to xray films. To determine the presence of male donor cells in female recipients, the membranes were probed with a 1,400 bp EcoRU SalI fragment of the pY2 plasmid," kindly provided by E. Palmer (National Jewish Hospital, Denver, CO). To estimate the quantity of DNA immobilized onto the membranes, these were rehybridized with the single copy M-CSF gene probe (1,100 bp), obtained by EcoRUHindIII digestion of plasmid pSPmM 1 '' kindly provided by P. Vassalli (Universitk de Genkve, Genkve, Switzerland). DNA from a pXTl infected NIH-3T3 clone (3T3-I), which does not hybridize with the pY2 probe and which contains one single copy of the retrovirus, was mixed in different proportions with untransduced spleen DNA of male mice, and used as a Y-chromosome/neo' internal standard. Genomic DNA from the 3T3-I clone digested with BamHI generates a junction fragment of 11.5 kb. 
RESULTS AND DISCUSSION
Clonal repertoire in the BM and PB CFU-S populations in mice mobilized with G-CSF. Mobilization of BM precursors is a new powerful strategy in hematopoietic transplantation whose biological insights need to be further elucidated so as to be totally exploited in experimental systems and in clinics. Aiming to define the repertoire and the repopulating properties of mobilized PBPCs with respect to BM precursor clones, retrovirally infected BM grafts were transplanted into irradiated recipients, so that genetically marked clones could be traced in these animals in the long-term (see Materials and Methods). After transplantation of the transduced marrow, animals were allowed to recover for at least 4 months. to allow the clonal stabilization of transplanted hematopoiesis.33 Thereafter, the mobilization of the progenitors was induced through the administration of G-CSF.I9 Animals were then killed, and genetic analyses and CFU-S and LTRC assays were performed as described in Fig 1. The clonal lympho-hematopoietic repopulation of three mobilized animals in which their BM and PB CFU-S populations were studied in parallel is shown in Figs 2 and 3 . In addition to the analysis of the BM, spleen, and thymus of these mice, these figures show the repertoire of clones found in representative series of spleen colony analyses. Table 1 includes the complete repertoire of clones found in these experiments, as well as the rate of clone expression in the BM and the PB CFU-S populations. The high extent of lympho-hematopoietic reconstitution by genetically marked cells (see Figs 2 and 3) and the fact that all 118 analyzed spleen colonies contained the proviral marker gene evidences the efficiency of the IE/S protocol for generating transduced populations of hematopoietic progenitors and LTRCs, in good consistency with earlier studies performed in our laboratory." This is especially remarkable when one takes into account the proliferative potential of the CFU-S population and the long-term posttransplantation period at which the analyses were made (4 to 1 I months posttransplantation).
The analysis of the junction fragments in DNA samples from mouse 4.1 showed that the clone which predominantly repopulated the BM and the spleen of this animal (clone A in Fig 2) was also present in most of the BM derived and PB derived spleen colonies (82% and 80% respectively, see Table I ). On the other hand, clones faintly represented or not represented at all in the BM or spleen of the primary recipient were rarely detected in the CFU-S populations (clones B-F in Table I ).
The analysis of mouse 4.2 showed that one clone (clone G in Fig 2) had predominantly repopulated the BM and spleen of this animal, whereas two main clones (G and H) were found in the thymus. Clone G was, in addition, well represented in the spleen colonies generated by BM and PB grafts (47% and 44%. respectively), while as it was the case in mouse 4.1, most of the clones that were poorly represented in the BM or the spleen of the mobilized animal were also rarely found within both CFU-S populations (clones I, K, L, and M). A modest expression of clones H and J was observed in the BM and spleen of the mobilized mouse. One of these clones (clone H) was very poorly represented in the BM and the PB CFU-S pools (7% and 0%. respectively), whereas the other one (clone J) was relatively well-expressed in both CFU-S populations (27% and 44% in BM and PB, respectively).
For
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The Southem blot in Fig 3 shows the clonal repopulation pattern of one animal that was mobilized 11 months after transplantation with the transduced BM. In this case, only three different repopulating clones were detected, probably as a result of the long posttransplantation period at which the analysis was made. Previous observations have shown that a gradual extinction of the less primitive repopulating clones is produced as the posttransplantation period is in~reased.",'~ Once again, the predominant clone found in the bulk of BM and spleen cells (clone N) was represented to a high, and also similar, extent in both the BM and the PB CFU-S populations (59% and 56%, respectively). A lower proportion of BM and PB derived spleen colonies was originated by clones 0 and P, which were also less represented in the BM and spleen.
As shown in Table 1 , the expression of the repopujating clones in the thymus had no influence on the frequency of clone expression in the CFU-S populations. This was most evident in the case of the thymus-specific clones D and E of animal 4.1 because none of the 32 tested spleen colonies that were derived from this animal was originated by any of these two clones. This observation is also supported by the detection of clones that were well represented in the CFU-S population, but not represented at all in the thymus (clone 0 of animal 11.1). Because of the long half-life of certain T-cell subpopulation^,^^ the presence of thymus-specific repopulating clones has not been considered indicative of the presence of self-renewing T-restricted stem cell^.'^^'^ From the clonal analysis of the BM and the mobilized PB CFU-S populations it is concluded that an almost identical repertoire of clones is present in both populations (see Table  1 ). Moreover, the correlation study presented in Fig 4 shows that the rate of expression of each repopulating clone in the BM and in the PB CFU-S populations follows a linear relationship ( r = .96) that overlaps with the line x = y. These results show for the first time that mobilized PBPCs do not represent a particular subpopulation of the progenitors residing in the BM. On the contrary, our data indicates that the clonal make-up of mobilized PB precursors is a close reflection, even in quantitative terms, of the repertoire of clones residing in the BM. According to this observation it is proposed that, at least in the case of G-CSF protocols, a generalized migration of the BM precursors accounts for the large number of hematopoietic progenitors that are currently found in mobilized PB samples.
Clonal repertoire and multipotentiality of mobilized PB and BM LTRCs. To determine whether precursor clones residing in the BM and in the mobilized PB were capable of conferring sustained lympho-hematopoietic reconstitution, these two types-of hematopoietic grafts were procured from two of the G-CSF treated animals (mice 4.1 and 4.2 in Fig 2) and further retransplanted to perform long-term studies. In each case, 5 X lo6 BM cellslmouse and 200 p L PB/mouse were transplanted into secondary recipients gathered into groups of three mice (see Fig 1) .
The secondary recipients that had been transplanted with BM and PB grafts of mouse 4.1 were analyzed at 4 to 7 months posttransplantation. In all analyzed recipients (one animal of the BM group died at 122 days posttransplantation) a monoclonal repopulation by the same clone which predominantly repopulated the hematopoiesis of the mobilized animal was observed (clone A; see mice PB 4.U7.1 and BM 4.117.1 in Fig 5) . The multipotential capacity of the clone was evidenced from these studies, both in the case of grafts procured from BM and mobilized PB.
The clonal repopulation pattem of secondary recipients that had been transplanted with BM and PB cells from mouse 4.2 is also shown in Fig 5. In this case, one of the animals that received only 20 p L of PB and that was not killed for the CFU-S studies remained alive for 10 months posttransplantation. Significantly, a complete lympho-hematopoietic repopulation by clone J was observed in this animal (mouse PB 4.2/10.1), as well as in two of the recipients which had been transplanted with 200 pL PB (the third recipient died at day 180 posttransplantation). When secondary BM recipients were analyzed, both a monoclonal (clone J) and an oligoclo- The predominant repopulation of these secondary recipients by genetically labeled cells is consistent with the data obtained in the CFU-S experiments, and confirms the efficiency of our infection procedure to generate BM grafts enriched in transduced progenitors and LTRCs. Moreover, the presence of common junction fragments in the BM, spleen, and thymus of the recipients that had been transplanted with the mobilized PBPCs supports the hypothesis that G-CSF, administered as a sole factor, is capable of mobilizing multipotent lympho-hematopoietic LTRC clones."
The comparative analysis of clones expressed in the longterm and in the spleen colony assays showed that no new clones can be recognized in the LTRC population, with respect to those identified in the CFU-S pool of precursors; something that would have suggested the long-term extinction of clones entering into the CFU-S compartment. On the contrary, data obtained from both the BM and the PB grafts shows that clones which are most frequently represented within the CFU-S population (clones A, G, and J) are characterized by a long-term reconstitution capacity (represented by LTR clones in Table I) , suggesting, at least in the case of G-CSF mobilized mice, that the rate of expression of a particular repopulating clone in the CFU-S compartment can be considered of prognostic value for the clone longevity.
The conclusions raised from this study support the hypothesis we have put forth in this report that the use of mobilized PBPCs may improve the possibilities of transplanting the complete repertoire of precursor clones residing in the BM. Based on this conclusion a new additional advantage should be considered for the use of mobilized PBPCs, in particular those mobilized with G-CSF, in place of hematopoietic grafts procured from limited areas of BM.
